Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection

Qi Zhang(Northeast Agricultural University), Yihong Ye(National Institute of Diabetes and Digestive and Kidney Diseases), Wei Zheng(Liaoning Cancer Hospital & Institute), Vivian Cao-Dao(National Institutes of Health), Peter Radvák(Slovak University of Technology in Bratislava), Hang Xie(Nanjing University of Chinese Medicine), Miao Xu(National Institutes of Health), Yue Xu(China Pharmaceutical University), Juhyung Lee(National Institute of Diabetes and Digestive and Kidney Diseases), Catherine Z. Chen(National Institutes of Health)
Scientific Reports
April 15, 2022
10.1038/s41598-022-10293-x
Cited by 24

Related Papers

Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
|Cell Discovery|2018|194